Treatment with 400 mg once-monthly injectable aripiprazole demonstrates efficacy in preventing recurrence of mood episodes in patients with bipolar I.
All articles by Natasha Dyal, MD
Transition from a once-monthly formulation of a long-acting, injectable paliperidone palmitate to a once-every-3-month formulation treatment regimen in patients with schizophrenia demonstrated increased adherence to antipsychotic medication.
Latest News Your top articles for Monday
Haymarket Medical NetworkTop Picks